Logo-jnp
J Nephropathol. 2017;6(1): 25-29. doi: 10.15171/jnp.2017.05
PMID: 28042550        PMCID: PMC5106879

Original Article

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients

Maryam Rahbar 1, Zahra Chitsazian 2 * , Firoozeh Abdoli 2, Seyed-Masoud Moeini Taba 2, Hosein Akbari 3

Cited by CrossRef: 5

1- Lee Y, Kim M, Lee M, Kim K, Lee N, Won J, Yoon S. A Retrospective Analysis of Bone Marrow Examination Results from a Single Center Institution: In What Situations Is Bone Marrow Examination Helpful?. Soonchunhyang Med Sci. 2022;28(2):90 [Crossref]
2- Wu Y, Cai X, Ni J, Lin X. Resolution of epoetin‐induced pure red cell aplasia, successful re‐challenge with roxadustat. Int J Lab Hematology. 2020;42(6) [Crossref]
3- Lacreta G, Bucharles S, Sevignani G, Riella M, Nascimento M. Pure red cell aplasia and anti-erythropoietin antibodies in patients on hemodialysis: a report of two cases and a literature review. Braz J Nephrol. 2019;41(1):145 [Crossref]
4- Yuan F, Wei F, Wang J, You Y. Clinical aspects and risk factors of lupus nephritis: a retrospective study of 156 adult patients. J Int Med Res. 2019;47(10):5070 [Crossref]